Sponsor
Here's the list:
AT&T Inc.
Price Target: $24.00
Paragraph 1: AT&T Inc. is the second largest wireless service provider in North America and one of the world's leading communications service carriers. Through its subsidiaries and affiliates, the company offers a wide range of communication and business solutions that include wireless, local exchange, long-distance, data/broadband and Internet, video, managed networking, wholesale and cloud-based services.
Paragraph 2: With assets like HBO, CNN and TNT, AT&T's acquisition of Time Warner has created new kinds of online videos and opened up avenues for targeted advertisements. The company is also focusing on streaming services with AT&T TV and HBO Max. This is likely to create other avenues to monetize content as it expands 5G coverage across the country.
Market Cap: $158.68B
Last Dividend Amount: $0.28
Expected Ex-Dividend Date: Jul 10 2024
Expected Payment Date: Aug 01 2024
Expected Dividend & Yield: 5.02%
Price Target: $204.00
Paragraph 1: AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi and Rinvoq position it well for long-term growth.
Paragraph 2: AbbVie came into existence after Abbott Laboratories divested its pharmaceutical division. AbbVie enjoys leadership positions in key therapeutic areas including immunology, hematologic oncology, neuroscience, aesthetics, eye care and womens' health. Humira is approved for several autoimmune diseases like rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis, Crohn's disease and others. Imbruvica became part of the company's portfolio following the Pharmacyclics acquisition. Other key drugs include Venclexta, Botox Cosmetic, Botox Therapeutics, Vraylar, Skyrizi and Rinvoq.
Market Cap: $347.90B
Last Dividend Amount: $1.55
Expected Ex-Dividend Date: Oct 15 2024
Expected Payment Date: Nov 15 2024
Expected Dividend & Yield: 3.15%
Price Target: $33.25
Paragraph 1: Hormel Foods Corporation is a leading manufacturer as well as marketer of various meat and food products in the U.S. and international markets. Its brands include Planters(TM), SKIPPY(TM), SPAM(TM), Hormel(TM), Natural Choice(TM), Applegate(TM), Justin's(TM), Wholly(TM), Hormel(TM), Black Label(TM), Columbus(TM), Jennie-O(TM) and more than 30 other brands.
Market Cap: $17.36B
Last Dividend Amount: $0.28
Expected Ex-Dividend Date: Oct 15 2024
Expected Payment Date: Nov 15 2024
Expected Dividend & Yield: 3.57%
Price Target: $123.00
Paragraph 1: Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products.
Paragraph 2: Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Market Cap: $197.58B
Last Dividend Amount: $0.55
Expected Ex-Dividend Date: Oct 15 2024
Expected Payment Date: Nov 15 2024
Expected Dividend & Yield: 1.94%
YOU MIGHT WANT TO WATCH THIS NEXT
The #1 Energy Passive Income Investment for 2024 |
It's not a stock, bond or private company... But this little-known alternative investment could hand you BIG MONTHLY INCOME from the oil and gas surge in 2024. CLICK HERE TO FIND OUT WHAT IT IS |